SKIN

The Beauty Health Company [SKIN] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

SKIN Stock Summary

Top 10 Correlated ETFs

SKIN


Top 10 Correlated Stocks

SKIN


In the News

05:38 29 May 2023 SKIN

7 Short-Squeeze Stocks Set for a May Rally

A practice designed for only the most daring traders, the best short-squeeze stocks to buy now could yield tremendous gains. To be sure, approaching this sector means staring at the possibility of severe losses in the face.

03:24 29 May 2023 SKIN

The Beauty Health Company (SKIN) Q1 2023 Earnings Call Transcript

The Beauty Health Company (NASDAQ:SKIN ) Q1 2023 Earnings Conference Call May 10, 2023 8:30 AM ET Company Participants Eduardo Rodriguez - Senior Director, M&A and Investor Relations Andrew Stanleick - President, Chief Executive Officer & Director Liyuan Woo - Chief Financial Officer Conference Call Participants Korinne Wolfmeyer - Piper Sandler & Co. Margaret Kaczor - William Blair & Company Olivia Tong - Raymond James & Associates Jonathan Block - Stifel, Nicolaus & Company Oliver Chen - TD Cowen Allen Gong - JPMorgan Chase & Co. Bruce Jackson - The Benchmark Company Linda Bolton-Weiser - D.A. Davidson & Co. Navann Ty - BNP Paribas Exane Kyle Rose - Canaccord Genuity Operator Good day, and welcome to the Beauty Health Company First Quarter 2023 Earnings Conference Call.

02:44 29 May 2023 SKIN

The Beauty Health Company: More Than Skin Deep

The company's core HydraFacial product is popular among consumers and beauticians. The company has a razor and blade business model with a lucrative and customisable consumables component.

03:12 29 May 2023 SKIN

7 Short-Squeeze Stocks That Could Make You Rich

While trading with the masses may generally be the wisest approach, contrarian gamblers may accrue dramatic profitability through short-squeeze stocks. To get everyone on the same page, coordinated investments in heavily shorted securities can potentially trigger ridiculous upside as bears panic out of their positions.

11:38 29 May 2023 SKIN

Why Is The Beauty Health Company Jumping Higher Today?

The medical device company is gaining traction with growing sales and profits.

02:24 29 May 2023 SKIN

7 Short-Squeeze Stocks to Buy Before They Soar

As much as we may recognize that short sellers perform a valuable service for the equities market, the concept of targeting short-squeeze stocks to buy just to penalize the pessimists carries cathartic value. Fundamentally, market bears operate like great white sharks.

03:40 29 May 2023 SKIN

The Beauty Health Company: A Good Long Term Bet

In 2023, revenue should benefit from healthy demand and an increasing footprint globally. Margins should benefit from operating leverage and normalized investment levels in 2023.

01:17 29 May 2023 SKIN

The Beauty Health Company (SKIN) Q3 2022 Earnings Call Transcript

The Beauty Health Company (NASDAQ:SKIN ) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Eduardo Rodriguez - Senior Director of M&A and IR Andrew Stanleick - President and CEO Liyuan Woo - CFO Conference Call Participants Oliver Chen - Cowen Korinne Wolfmeyer - Piper Sandler Jon Block - Stifel Margaret Kaczor - William Blair Allen Gong - JPMorgan Ashley Helgans - Jefferies Kyle Rose - Canaccord Genuity Bruce Jackson - The Benchmark Company Devin Weinstein - Raymond James Linda Bolton Weiser - D.A. Davidson Operator Ladies and gentlemen, good morning, and welcome to Beauty Health Company Third Quarter 2022 Earnings Call.

03:41 29 May 2023 SKIN

The Beauty Health Company: A Compelling Mid To Long-Term Growth Story

The Beauty Health Company's new mid-term targets highlight the impressive (but achievable) growth opportunities at hand. As the model benefits from operating leverage, more revenue growth should yield significant margin expansion as well.

05:10 29 May 2023 SKIN

This High-Growth, Under-the-Radar Stock Has 80% Upside, According to Wall Street

BeautyHealth's HydraFacial platform is popular, management is building a solid track record, and the business is outperforming expectations.

SKIN Financial details

Company Rating
Strong Buy
Market Cap
1.11B
Income
-10.32M
Revenue
376.76M
Book val./share
1.11
Cash/share
4.02
Dividend
-
Dividend %
-
Employees
1.03K
Optionable
No
Shortable
Yes
Earnings
07 Aug 2023
P/E
-107.75
Forward P/E
-
PEG
11.04
P/S
2.96
P/B
7.54
P/C
2.08
P/FCF
-11.72
Quick Ratio
8.36
Current Ratio
10.35
Debt / Equity
5.74
LT Debt / Equity
5.06
-
-
EPS (TTM)
-0.09
EPS next Y
-
EPS next Q
-
EPS this Y
-108.17%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
26.64%
Revenue Q/Q
-12.06%
EPS Q/Q
-666.67%
-
-
-
-
SMA20
-16.67%
SMA50
-16.67%
SMA100
11.11%
Inst Own
67.85%
Inst Trans
0.5%
ROA
-1%
ROE
-4%
ROC
-0.03%
Gross Margin
67%
Oper. Margin
-8%
Profit Margin
-3%
Payout
-
Shs Outstand
132.65M
Shs Float
75.4M
-
-
-
-
Target Price
26
52W Range
8.2001-16.02
52W High
-47.78%
52W Low
+4.44%
RSI
30
Rel Volume
3.02
Avg Volume
1.76M
Volume
5.32M
Perf Week
-18.01%
Perf Month
-38.11%
Perf Quarter
-24.25%
Perf Half Y
-16.37%
-
-
-
-
Beta
1.11665
-
-
Volatility
0.63%, 1.23%
Prev Close
-13.6%
Price
8.355
Change
-13.24%

SKIN Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
Revenue per share
0.91.330.952.552.48
Net income per share
0-0.01-0.23-3.670.3
Operating cash flow per share
-0.010.01-0.1-0.28-0.72
Free cash flow per share
-0.07-0.07-0.13-0.43-0.84
Cash per share
00.060.088.833.85
Book value per share
0-0.01-0.242.961.16
Tangible book value per share
0-1.28-1.431.20
Share holders equity per share
0-0.01-0.242.961.16
Interest debt per share
01.651.97.35.19
Market cap
1.36B1.36B1.42B2.47B1.34B
Enterprise value
01.54B1.63B2.3B1.53B
P/E ratio
-4.29K-829.87-48.61-6.5830.25
Price to sales ratio
12.18.1611.919.493.67
POCF ratio
-1.52K786.64-114.05-86.99-12.6
PFCF ratio
-154.73-156.35-87.26-56.1-10.83
P/B Ratio
0-1.13K-47.348.167.83
PTB ratio
0-1.13K-47.348.167.83
EV to sales
09.2513.658.824.17
Enterprise value over EBITDA
055.3-574.73-26.03-91.1
EV to operating cash flow
0892.24-130.69-80.93-14.32
EV to free cash flow
0-177.34-100-52.19-12.31
Earnings yield
00-0.02-0.150.03
Free cash flow yield
-0.01-0.01-0.01-0.02-0.09
Debt to equity
0-188.38-8.443.034.88
Debt to assets
01.011.130.750.83
Net debt to EBITDA
06.55-73.211.95-10.96
Current ratio
01.431.9113.0910.79
Interest coverage
10.79-0.81-3.11-1.81
Income quality
2.82-1.050.430.08-2.4
Dividend Yield
0.070000
Payout ratio
-311.390000
Sales general and administrative to revenue
0.160.160.260.380.29
Research and developement to revenue
0.020.030.030.030.02
Intangibles to total assets
00.70.670.150.17
Capex to operating cash flow
8.81-6.030.310.550.16
Capex to revenue
-0.07-0.06-0.03-0.06-0.05
Capex to depreciation
-0.69-0.75-0.27-0.74-0.79
Stock based compensation to revenue
0000.050.08
Graham number
00.051.1215.642.8
ROIC
00.04-0.070.060.15
Return on tangible assets
0-0.02-0.4-0.360.05
Graham Net
0-1.54-1.710.41-1.03
Working capital
016.35M28.17M924.46M715.98M
Tangible asset value
0-160.02M-179.43M122.59M497K
Net current asset value
0-173.39M-193.7M84.38M-48.33M
Invested capital
0-157.1-7.232.434.38
Average receivables
0023.45M37.31M64.6M
Average payables
0016.37M23.77M29.69M
Average inventory
0021.32M29.23M75.85M
Days sales outstanding
051.9671.0672.1777.59
Days payables outstanding
086.57130.02135.4895.83
Days of inventory on hand
0118.01163.2164.46367.82
Receivables turnover
07.025.145.064.7
Payables turnover
04.222.812.693.81
Inventory turnover
03.092.242.220.99
ROE
01.360.97-1.240.26
Capex per share
-0.06-0.08-0.03-0.15-0.12

Quarterly Fundamentals Overview

Last date of statement is 2023-03-31 for Q1

Metric History 2022-03-312022-06-302022-09-302022-12-31 2023-03-31
Revenue per share
0.50.690.590.710.65
Net income per share
0.220.0500.03-0.17
Operating cash flow per share
-0.26-0.21-0.21-0.04-0.1
Free cash flow per share
-0.28-0.23-0.26-0.06-0.1
Cash per share
5.715.454.544.114.02
Book value per share
2.272.341.711.241.11
Tangible book value per share
1.11.170.590-0.37
Share holders equity per share
2.272.341.711.241.11
Interest debt per share
4.9854.995.465.71
Market cap
2.54B1.94B1.78B1.26B1.67B
Enterprise value
2.43B1.87B1.84B1.44B1.89B
P/E ratio
19.5561.13.39K82.41-18.83
Price to sales ratio
33.7118.7220.0212.8219.38
POCF ratio
-66.08-61.86-56.62-233.19-128.55
PFCF ratio
-60.68-55.8-45.42-153.05-128.55
P/B Ratio
7.445.56.897.3311.33
PTB ratio
7.445.56.897.3311.33
EV to sales
32.2218.0320.7614.6921.93
Enterprise value over EBITDA
-309.57658.6-1.13K2.72K-151.41
EV to operating cash flow
-63.16-59.59-58.69-267.24-145.47
EV to free cash flow
-58-53.75-47.09-175.39-145.47
Earnings yield
0.01000-0.01
Free cash flow yield
-0.02-0.02-0.02-0.01-0.01
Debt to equity
2.512.453.284.885.74
Debt to assets
0.720.710.770.830.85
Net debt to EBITDA
14.3-25.14-39.97346.4-17.61
Current ratio
14.2511.4411.6810.7910.35
Interest coverage
-3.81-0.55-1.23-1.52-5.09
Income quality
-1.18-3.95-239.7-1.410.58
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.350.270.270.290.35
Research and developement to revenue
0.030.030.020.010.03
Intangibles to total assets
0.150.140.150.170.2
Capex to operating cash flow
0.090.110.250.520
Capex to revenue
-0.05-0.03-0.09-0.030
Capex to depreciation
-0.57-0.74-1.36-0.50
Stock based compensation to revenue
0.090.060.080.080.04
Graham number
3.321.660.180.882.05
ROIC
0.02000.050.14
Return on tangible assets
0.030.0100-0.03
Graham Net
0.480.37-0.32-1.1-1.51
Working capital
913.46M908.7M815.99M715.98M676.2M
Tangible asset value
165.39M177.1M88.54M497K-48.4M
Net current asset value
124.92M133.13M45.55M-48.33M-98.8M
Invested capital
2.192.132.914.385.1
Average receivables
57M71.75M82.81M81.23M75.09M
Average payables
28.01M31.9M34.7M31.46M32.32M
Average inventory
41.15M60.28M87.62M109.07M119.27M
Days sales outstanding
74.6770.3585.8471.3375.5
Days payables outstanding
103.36103.97107.7282.8395.87
Days of inventory on hand
180.3207.56336.32317.93341.27
Receivables turnover
1.211.281.051.261.19
Payables turnover
0.870.870.841.090.94
Inventory turnover
0.50.430.270.280.26
ROE
0.10.0200.02-0.15
Capex per share
-0.02-0.02-0.05-0.020

SKIN Frequently Asked Questions

What is The Beauty Health Company stock symbol ?

The Beauty Health Company is a US stock , located in Long beach of Ca and trading under the symbol SKIN

Is The Beauty Health Company buy or a sell ?

1 stock analysts have 1 predictions with a medium analyst target price of $26. The lowest prediction is $26 and the highest is $26

What is SKIN stock prediction ?

What is The Beauty Health Company stock quote today ?

The Beauty Health Company stock price is $8.355 today.

Is The Beauty Health Company stock public?

Yes, The Beauty Health Company is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap